Labcorp (LH)
(Delayed Data from NYSE)
$218.46 USD
+1.89 (0.87%)
Updated Mar 28, 2024 04:00 PM ET
After-Market: $218.45 -0.01 (0.00%) 7:58 PM ET
3-Hold of 5 3
A Value C Growth D Momentum B VGM
Price, Consensus and EPS Surprise
LH 218.46 +1.89(0.87%)
Will LH be a Portfolio Killer in March?
Zacks Investment Research is releasing its prediction for LH based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for LH
Labcorp (LH) Boost Diagnostics Suite With New Biomarker Test
Labcorp (LH) Presents New Research on Precision Diagnostics
LH: What are Zacks experts saying now?
Zacks Private Portfolio Services
Labcorp (LH) Expands Strategic Alliances, Test Sales Fall
LH or COO: Which Is the Better Value Stock Right Now?
Are Investors Undervaluing Labcorp (LH) Right Now?
Other News for LH
Labcorp Expands Diagnostic Reach With Strategic Deal For Select Assets Of BioReference Health
Labcorp Announces Acquisition of Select Assets of BioReference Health's Diagnostics Business
Labcorp to buy select assets from OPKO’s BioReference Health
Labcorp to acquire select assets of BioReference Health for $237.5M
What You Missed On Wall Street On Thursday